Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital

Journal of Infection and Public Health

Volumn 8, Issue 3, 2015, Pages 242-247

  Elabd, Faten M ^a   Al Ayed, Mohamed S Z ^b   Asaad, Ahmed M ^b   Alsareii, Saeed A ^b   Qureshi, Mohamed A ^b   Musa, Hassan A A ^c  

^a ASEER CENTRAL HOSPITAL   (Saudi Arabia)

^b NAJRAN UNIVERSITY   (Saudi Arabia)

^c NATIONAL RIBAT UNIVERSITY   (Sudan)

Author keywords

Acinetobacter baumannii; Antibiotics; Carbapenemases; PCR

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BACTERIAL DNA; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OXACILLINASE; PIPERACILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CHILD; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; GENE IDENTIFICATION; GENE INSERTION SEQUENCE; GENE TARGETING; GENETIC SCREENING; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SAUDI ARABIA; SKIN INFECTION; SOFT TISSUE INFECTION; TERTIARY CARE CENTER; URINARY TRACT INFECTION; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SECRETION (PROCESS); VERY ELDERLY; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DNA, BACTERIAL; FEMALE; HOSPITALS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; SAUDI ARABIA; YOUNG ADULT;

EID: 84928430896     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2014.10.002     Document Type: Article

References (30)

1. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
2. Gales A.C., Jones R.N., Sader H.S. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09). J Antimicrob Chemother 2011, 66:2070-2074.
3. Kuo H.Y., Chang K.C., Kuo J.W., Yueha H.W., Liouf M.L. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii. Int J Antimicrob Agents 2012, 39:33-38.
4. Asaad A.M., Al-Ayed M.S., Qureshi M.A. Emergence of unusual nonfermenting Gram-negative nosocomial pathogens in a Saudi Hospital. Jpn J Infect Dis 2013, 66:507-511.
5. Memish Z.A., Shibl A.M., Kambal A.M.Y.A., Ohaly Y.A., Ishaq A., Livermore D.M. Antimicrobial resistance among non-fermenting Gram-negative bacteria in Saudi Arabia. J Antimicrob Chemother 2012, 67:1701-1705.
6. Sinha M., Srinivasa H. Mechanisms of resistance to carbapenems in meropenem-resistant Acinetobacter isolates from clinical samples. Int J Med Microbiol 2007, 25:121-125.
7. Higgins P.G., Perez-Llarena F.J., Zander E., Fernandez A., Bou G., Seiferta H. OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 2013, 57(5):2121-2126. 10.1128/AAC.02413-12.
8. Poirel L., Naas T., Nordmann P. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother 2010, 54:24-38.
9. Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Pike R., Livermore D.M., et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006, 258:72-77.
10. Gur D., Korten V., Unal S., Deshpande L.M., Castanheira M. Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites. J Med Microbiol 2008, 57:1529-1532.
11. Nowak P., Paluchowska P., Budak A. Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland. New Microbiol 2012, 35:317-325.
12. Villalon P., Valdezate S., Medina-Pascual M.J., Carrasco G., Vindel A., Saez-Nieto J.A. Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-β-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain. J Antimicrob Chemother 2013, 68:550-553.
13. Al-Agamy M.H., Shibl A.M., Ali M.S., Khubnani H., Radwan H.H., Livermore D.M. Distribution of β-lactamases in carbapenem-non-susceptible Acinetobacter baumannii in Riyadh, Saudi Arabia. J Global Antimicrob Res 2014, 2:17-21. 10.1016/j.jgar.2013.08.004.
14. Al-Arfaj A.A., Ibrahim A.S., Somily A.M., Al-Salamah A.A. Genetic basis of carba-penem resistance in Acinetobacter clinical isolates in Saudi Arabia. Afr J Biotech 2011, 10:14186-14196.
15. Aly M., Tayeb H.T., Al Johani S.M., Alyamani E.J., Aldughaishem F., Alabdulkarim I., et al. Genetic diversity of OXA-51-like genes among multidrug-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur J Clin Microbiol Infect Dis 2014, 10.1007/s10096-014-2068-0.
16. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
17. Murray P.R., Baron E.J., Pfaller M.A. Manual of clinical microbiology handbook 2003, ASM Press, Washington, DC.
18. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 22nd informational supplement; M100-S22 2012, CLSI, Wayne, PA.
19. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006, 27:351-353.
20. Xia W., Chen Y., Mei Y., Wang T., Liu G., Gu B., et al. Changing trend of antimicrobial resistance among pathogens isolated from lower respiratory tract at a university affiliated hospital of China, 2006-2010. J Thorac Dis 2012, 4:284-291.
21. OXA genes among Acinetobacter spp. isolated from patients at Tehran hospitals. Jpn J Infect Dis 2008, 61:274-278.
22. Ting X.U., Xia W., Rong G., Pan S., Huang P., Gu B. A 4-year surveillance of antimicrobial resistance patterns of Acinetobacter baumanni in a university-affiliated hospital in China. J Thorac Dis 2013, 5(4):506-512. 10.3978/j.issn.2072-1439.2013.08.36.
23. Ben R.J., Yang M.C., Hsueh J.C., Shiang J.C., Chien S.T. Molecular characterization of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan. Int J Antimicrob Agents 2013, 38:403-408.
24. Howard A., O'Donoghue M., Feeney A., Sleator R.D. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence 2012, 3:243-250.
25. OXA-51-like gene that is intrinsic to A. baumannii. Antimicrob Agents Chemother 2012, 56:1124-1127.
26. OXA-23 gene associated with ISAba4 in Belgium. Antimicrob Agents Chemother 2008, 52:4205-4206.
27. OXA-23 collected from hospitals in Rio de Janeiro. Brazil Int J Antimicrob Agents 2009, 34:25-28.
28. Merkier A.K., Catalano M., Ramírez M.S., Quiroga C., Orman B., Ratier L., et al. Polyclonal spread of bla (OXA-23) and bla (OXA-58) in Acinetobacter baumannii isolates from Argentina. J Infect Dev Ctries 2008, 2:235-240.
29. Niumsup P.R., Boonkerd N., Tansawai U., Tiloklurs M. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand. Jpn J Infect Dis 2009, 62:152-154.
30. Qi C., Malczynskim M., Parker M., Scheetz M.H. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J Clin Microbiol 2008, 46:1106-1109.